To the content
4 . 2017

The possibilities of clinical use of glibenclamide in the 21st century

AbstractGLibencLamide is a drug of the II generation of sulfonylureas and is one of the most popular and studied of gLucose-Lowering drugs, which is more than 60 years is used in many countries as a reLiabLe and time-tested means of therapy of diabetes of type 2. In experimentaL and cLinicaL studies, gLibencLamide not onLy is the standard for evaLuation of new gLucose-Lowering drugs and therapeutic approaches, but aLso demonstrates potentiaLLy usefuL additionaL properties. This review presents the traditionaL information of the drug and prospects for the use of gLibencLamide in cLinicaL practice.

Keywords:diabetes mellitus, sulfonylureas, glibenclamide, pleiotropy effects

Endocrinology: News, Opinions, Training. 2017; (4): 33-43.
DOI: 10.24411/2304-9529-2017-00052


All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Ametov Alexander S.
Honored Scientist of the Russian Federation, Doctor of Medical Sciences, Professor, Head of Subdepartment of Endocrinology, Head of the UNESCO Network Chair on the subject «Bioethics of diabetes as a global problem» of the Russian Medical Academy of Continuous Professional Education (Moscow)
Вскрытие

Journals of «GEOTAR-Media»